Benjamin J. Zeskind
PRESIDENT AND CEO, Director · Immuneering Corp
- 2025
- Jun 24, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Benjamin J. Zeskind files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Thomas J. Schall - $101K in IMRX purchases and sales in the last 12 months
- Peter Feinberg - $87K in IMRX purchases and sales in the last 12 months
- Brett Matthew Hall - $36K in IMRX purchases and sales in the last 12 months
- Harold Eugene Brakewood - $25K in IMRX purchases and sales in the last 12 months
- Leah R. Neufeld - $11K in IMRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Benjamin J. Zeskind?
Benjamin J. Zeskind is a corporate insider, tracked as PRESIDENT AND CEO, Director of Immuneering Corp (IMRX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Benjamin J. Zeskind last file a Form 4?
The most recent primary Form 4 on record is dated 24 June 2026, one of 3 filings going back to 2025.
Has Benjamin J. Zeskind been buying or selling stock?
Recorded transactions: 3 open-market purchases ($46K) and 0 open-market sales across all tracked filings.
